Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alpha 1 Antitrypsin Deficiency Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alpha 1 Antitrypsin Deficiency Treatmentmarket, defines the market attractiveness level of Alpha 1 Antitrypsin Deficiency Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alpha 1 Antitrypsin Deficiency Treatment industry, describes the types of Alpha 1 Antitrypsin Deficiency Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alpha 1 Antitrypsin Deficiency Treatment market and the development prospects and opportunities of Alpha 1 Antitrypsin Deficiency Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alpha 1 Antitrypsin Deficiency Treatment market in Chapter 13.
By Player:
Teva Pharmaceutical Industries
GlaxoSmithKline
Biogen
Shire
Kamada Ltd
Baxalta
Abeona Therapeutics
LFB Biomedicaments
Chiesi Pharmaceuticals
AstraZeneca
ProMetic Life Sciences
Grifols
Baxter
CSL Behring
Pfizer
Boehringer Ingelheim
Arrowhead Research Corporation
Curaxys
Applied Genetic Technologies
ProBioGen
By Type:
Augmentation Therapy
Bronchodilators
Corticosteroids
Oxygen Therapy
By End-User:
Oxygen Therapy
Oxygen Therapy
Oxygen Therapy
Oxygen Therapy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alpha 1 Antitrypsin Deficiency Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alpha 1 Antitrypsin Deficiency Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alpha 1 Antitrypsin Deficiency Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alpha 1 Antitrypsin Deficiency Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alpha 1 Antitrypsin Deficiency Treatment Market Analysis and Outlook to 2022
-
7.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.2 United States Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.4 China Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.5 Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.6 India Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
-
7.7 South Korea Alpha 1 Antitrypsin Deficiency Treatment Consumption (2017-2022)
8 Region and Country-wise Alpha 1 Antitrypsin Deficiency Treatment Market Analysis and Outlook to 2028
-
8.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.2 United States Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.4 China Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.6 India Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)
9 Global Alpha 1 Antitrypsin Deficiency Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Augmentation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
10 Global Alpha 1 Antitrypsin Deficiency Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Augmentation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
11 Global Alpha 1 Antitrypsin Deficiency Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alpha 1 Antitrypsin Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alpha 1 Antitrypsin Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alpha 1 Antitrypsin Deficiency Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alpha 1 Antitrypsin Deficiency Treatment Market Competitive Analysis
-
14.1 Teva Pharmaceutical Industries
-
14.1.1 Teva Pharmaceutical Industries Company Details
-
14.1.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.3 Biogen
-
14.3.1 Biogen Company Details
-
14.3.2 Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biogen Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.4 Shire
-
14.4.1 Shire Company Details
-
14.4.2 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.5 Kamada Ltd
-
14.5.1 Kamada Ltd Company Details
-
14.5.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.6 Baxalta
-
14.6.1 Baxalta Company Details
-
14.6.2 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.7 Abeona Therapeutics
-
14.7.1 Abeona Therapeutics Company Details
-
14.7.2 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.8 LFB Biomedicaments
-
14.8.1 LFB Biomedicaments Company Details
-
14.8.2 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.9 Chiesi Pharmaceuticals
-
14.9.1 Chiesi Pharmaceuticals Company Details
-
14.9.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.11 ProMetic Life Sciences
-
14.11.1 ProMetic Life Sciences Company Details
-
14.11.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.12 Grifols
-
14.12.1 Grifols Company Details
-
14.12.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.13 Baxter
-
14.13.1 Baxter Company Details
-
14.13.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.14 CSL Behring
-
14.14.1 CSL Behring Company Details
-
14.14.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.15 Pfizer
-
14.15.1 Pfizer Company Details
-
14.15.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.16 Boehringer Ingelheim
-
14.16.1 Boehringer Ingelheim Company Details
-
14.16.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.17 Arrowhead Research Corporation
-
14.17.1 Arrowhead Research Corporation Company Details
-
14.17.2 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.18 Curaxys
-
14.18.1 Curaxys Company Details
-
14.18.2 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.19 Applied Genetic Technologies
-
14.19.1 Applied Genetic Technologies Company Details
-
14.19.2 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
14.20 ProBioGen
-
14.20.1 ProBioGen Company Details
-
14.20.2 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alpha 1 Antitrypsin Deficiency Treatment
-
Figure Alpha 1 Antitrypsin Deficiency Treatment Picture
-
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption by Country (2017-2022)
-
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alpha 1 Antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Augmentation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Augmentation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alpha 1 Antitrypsin Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alpha 1 Antitrypsin Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Kamada Ltd (Foundation Year, Company Profile and etc.)
-
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Baxalta (Foundation Year, Company Profile and etc.)
-
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Abeona Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table LFB Biomedicaments (Foundation Year, Company Profile and etc.)
-
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Chiesi Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table ProMetic Life Sciences (Foundation Year, Company Profile and etc.)
-
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Arrowhead Research Corporation (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Curaxys (Foundation Year, Company Profile and etc.)
-
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table Applied Genetic Technologies (Foundation Year, Company Profile and etc.)
-
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
Table ProBioGen (Foundation Year, Company Profile and etc.)
-
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Product and Service
-
